ID: ALA1929457

Max Phase: Preclinical

Molecular Formula: C15H16N6O

Molecular Weight: 296.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ncc(Cn2cc(COc3ccccc3)nn2)c(N)n1

Standard InChI:  InChI=1S/C15H16N6O/c1-11-17-7-12(15(16)18-11)8-21-9-13(19-20-21)10-22-14-5-3-2-4-6-14/h2-7,9H,8,10H2,1H3,(H2,16,17,18)

Standard InChI Key:  LDHXDHASNDWZPB-UHFFFAOYSA-N

Associated Targets(non-human)

Fusarium graminearum 1554 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rhizoctonia solani 2251 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Botrytis cinerea 4183 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Alternaria solani 773 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Alternaria alternata 757 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Microcystis aeruginosa 27 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Synechocystis sp. PCC 6803 30 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 296.33Molecular Weight (Monoisotopic): 296.1386AlogP: 1.59#Rotatable Bonds: 5
Polar Surface Area: 91.74Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.97CX LogP: 1.65CX LogD: 1.64
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.77Np Likeness Score: -1.68

References

1. Ren Y, He J, Feng L, Liao X, Jin J, Li Y, Cao Y, Wan J, He H..  (2011)  Structure-based rational design of novel hit compounds for pyruvate dehydrogenase multienzyme complex E1 components from Escherichia coli.,  19  (24): [PMID:22078411] [10.1016/j.bmc.2011.10.035]
2. He J, Feng L, Li J, Tao R, Wang F, Liao X, Sun Q, Long Q, Ren Y, Wan J, He H..  (2012)  Design, synthesis and biological evaluation of novel 2-methylpyrimidine-4-ylamine derivatives as inhibitors of Escherichia coli pyruvate dehydrogenase complex E1.,  20  (5): [PMID:22305934] [10.1016/j.bmc.2012.01.019]
3. He H, Wang W, Zhou Y, Xia Q, Ren Y, Feng J, Peng H, He H, Feng L..  (2016)  Rational design, synthesis and biological evaluation of 1,3,4-oxadiazole pyrimidine derivatives as novel pyruvate dehydrogenase complex E1 inhibitors.,  24  (8): [PMID:26972920] [10.1016/j.bmc.2016.03.011]
4. Feng J, He H, Zhou Y, Guo X, Liu H, Cai M, Wang F, Feng L, He H..  (2019)  Design, synthesis and biological evaluation of novel inhibitors against cyanobacterial pyruvate dehydrogenase multienzyme complex E1.,  27  (12): [PMID:30692021] [10.1016/j.bmc.2019.01.021]

Source